Recent News

• 03.23.2026 - NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™
• 03.10.2026 - NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer’s Disease at AD/PD™ 2026

Recent Filings

• 02.26.2026 - 8-K Current report
• 02.05.2026 - 8-K Current report
• 01.26.2026 - 8-K Current report
• 01.20.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 01.16.2026 - 8-K Current report
• 01.09.2026 - 8-K Current report
• 10.08.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 09.29.2025 - 8-K Current report
• 09.24.2025 - 8-K Current report
• 09.09.2025 - 8-K Current report